Global /India /Healthcare /Drug Manufacturers - Specialty & Generic /RPGLIFE
chevron_leftBack

RPG Life Sciences Ltd.

RPGLIFE
NSE: RPGLIFE Delayed
2,315.70INR 2.6%
27.08 USD
As of 24 April 2025, RPG Life Sciences Ltd. has a market cap of $437.58M USD, ranking #12695 globally and #831 in India. It ranks #1246 in the Healthcare sector, and #298 in the Drug Manufacturers - Specialty & Generic industry.
Global Rank
12695
Country Rank
831
Sector Rank
1246
Industry Rank
298
Key Stats
Market Cap
$437.58MUSD
37.34B INR
Enterprise Value
$421.98MUSD
36.08B INR
Revenue (TTM)
$74.69MUSD
6.37B INR
EBITDA (TTM)
$17.74MUSD
1.52B INR
Net Income (TTM)
$9.27MUSD
791.3M INR
EBITDA Margin
24%
Profit Margin
12%
PE Ratio
47.2
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Yugal Kishor Sikri open_in_new
Employees
1,270
Founded
1968
Website
rpglifesciences.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
2.6% 9.4% -3.3% 5% -18% 51%
Upcoming Earnings
Earnings Date
Mon, Apr 28

Markets

Exchange Ticker Price
National Stock Exchange of India
MIC: XNSE
PRIMARY
RPGLIFE
RPG Life Sciences Ltd
ISIN: INE105J01010
Shares Out.:
16.539M1 Shares Float: 3.987M2
TV:
SA:
YF:
GF:
BA:
MS:
2.32K INR
Bombay Stock Exchange
MIC: XBOM
532983 (RPGLIFE)
RPG Life Sciences Ltd
ISIN: INE105J01010
TV:
SA:
YF:
GF:
BA:
MS:
2.06K INR
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About RPG Life Sciences Ltd.

RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally. The company offers synthetic APIs in various therapeutic categories, including immunosuppressants, anti-psychotic, anti-anginal, anthelmentics, anti-convulsant, and anti-spasmodic, etc. It also provides generics for immunosuppressant therapy; and finished dosage formulations for various therapies, which include nephrology, rheumatology, oncology, gastroenterology, cardiology, orthopedics, nutritional, diabetology, respiratory, neuropsychiatry, urology, vitamins and minerals, gastrointestinal, pain management, anti-diabetic, gynecology, cardiovascular, pediatrics, neurology, anti-dengue, and dermatology, etc. The company was formerly known as RPG Pharmaceuticals Limited and changed its name to RPG Life Sciences Limited in February 2008. RPG Life Sciences Limited was founded in 1968 and is headquartered in Mumbai, India. RPG Life Sciences Limited is a subsidiary of Nucleus Life Trust.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (India)
Name
Market Cap diff.
Sun Pharmaceutical Industries Ltd.
SUNPHARMA
$49.08B
4.19T INR
11K%
Divi's Laboratories Ltd.
DIVISLAB
$18.39B
1.57T INR
4K%
Cipla Ltd.
CIPLA
$14.46B
1.23T INR
3K%
Torrent Pharmaceuticals Ltd.
TORNTPHARM
$13.21B
1.13T INR
3K%
Mankind Pharma Ltd.
MANKIND
$12.47B
1.06T INR
3K%
Industry: Drug Manufacturers - Specialty & Generic (Global)
Name
Market Cap diff.
Zoetis Inc.
ZTS
$67.32B
15K%
Merck KGaA
MRK
$59.42B
52.43B EUR
13K%
Takeda Pharmaceutical Company Ltd.
4502
$46.31B
6.6T JPY
10K%
Haleon plc
HLN
$45.57B
34.34B GBP
10K%
Galderma Group AG
GALD
$23.06B
19.13B CHF
5K%